A high expression of glutamine: fructose-6-phosphate amidotransferase (GFAT1), the rate-limiting enzyme that converts fructose-6-phosphate into glucosamine-6-phosphate (Figure 1), correlates with poor HCC patient prognosis [55]. This evidence concerns the gene GFPT1 and hepatocellular carcinoma.